Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Exponent
EXPO
$3.22B
| $14.3M | 0.04% |
+966,400
| New | +$13.3M |
|
577
Revvity
RVTY
$13.2B
| $14.2M | 0.04% |
+438,000
| New | +$14.3M |
|
578
Diana Shipping
DSX
$296M
| $14.2M | 0.04% |
+2,026,914
| New | +$13.9M |
|
579
EXL Service
EXLS
$5.2B
| $14.2M | 0.04% |
+2,404,000
| New | +$14.7M |
|
|
HUB.B
580
DELISTED
HUBBELL INC CL-B
HUB.B
| $14.2M | 0.04% |
+143,200
| New | +$13.9M |
|
581
Companhia Siderúrgica Nacional
SID
$1.15B
| $14.1M | 0.04% |
+5,094,400
| New | +$18.2M |
|
582
Royal Gold
RGLD
$19.7B
| $14.1M | 0.04% |
+334,409
| New | +$18.1M |
|
|
QLGC
583
DELISTED
QLOGIC CORP
QLGC
| $14M | 0.04% |
+1,466,679
| New | +$14.9M |
|
584
NVR
NVR
$16.8B
| $14M | 0.04% |
+15,200
| New | +$15.1M |
|
|
SBNY
585
DELISTED
Signature Bank
SBNY
| $13.9M | 0.04% |
+167,574
| New | +$12.9M |
|
|
MDC
586
DELISTED
M.D.C. Holdings, Inc.
MDC
| $13.9M | 0.04% |
+594,234
| New | +$15.4M |
|
587
Timken Company
TKR
$9.03B
| $13.8M | 0.04% |
+343,243
| New | +$13.6M |
|
588
NOV
NOV
$7.45B
| $13.8M | 0.04% |
+222,144
| New | +$13.7M |
|
589
Allstate
ALL
$64.7B
| $13.7M | 0.04% |
+285,300
| New | +$13.9M |
|
590
Strategic Education
STRA
$1.81B
| $13.7M | 0.04% |
+281,000
| New | +$14.1M |
|
|
ASCMA
591
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $13.7M | 0.04% |
+175,670
| New | +$12.5M |
|
592
Northwest Bancshares
NWBI
$2.3B
| $13.6M | 0.04% |
+1,003,854
| New | +$12.6M |
|
593
Banco de Chile
BCH
$20.2B
| $13.5M | 0.04% |
+523,420
| New | +$13.8M |
|
594
Synaptics
SYNA
$4.3B
| $13.5M | 0.04% |
+349,800
| New | +$14M |
|
|
DCT
595
DELISTED
DCT Industrial Trust Inc.
DCT
| $13.5M | 0.04% |
+471,400
| New | +$14.3M |
|
|
LPS
596
DELISTED
LENDER PROCESSING SERVICES INC
LPS
| $13.5M | 0.04% |
+416,700
| New | +$12.1M |
|
|
BTU
597
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $13.4M | 0.04% |
+61,080
| New | +$17.6M |
|
|
GHL
598
DELISTED
Greenhill & Co., Inc.
GHL
| $13.4M | 0.04% |
+292,100
| New | +$14.1M |
|
599
Texas Capital Bancshares
TCBI
$4.38B
| $13.3M | 0.03% |
+300,300
| New | +$12.8M |
|
600
Calumet Specialty Products
CLMT
$4.15B
| $13.3M | 0.03% |
+365,400
| New | +$13.1M |
|
Similar funds
Jim Simons's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Jim Simons, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Jim Simons's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Jim Simons disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.